No. 24-1132
Purdue Pharma L.P., et al. v. Accord Healthcare, Inc.
Tags: federal-circuit non-obviousness obviousness patent-law pharmaceutical-innovation secondary-considerations
Key Terms:
Antitrust Patent JusticiabilityDoctri
Antitrust Patent JusticiabilityDoctri
Latest Conference:
2025-09-29
Question Presented (from Petition)
Whether, as this Court has held, the objective indicia of non-obviousness should be analyzed flexibly to combat hindsight bias or instead subject to the Federal Circuit's rigid rules restricting the inquiry.
Question Presented (AI Summary)
Whether the objective indicia of non-obviousness should be analyzed flexibly to combat hindsight bias or subject to the Federal Circuit's rigid rules restricting the inquiry
Docket Entries
2025-10-06
Petition DENIED.
2025-06-17
DISTRIBUTED for Conference of 9/29/2025.
2025-06-17
Reply of Purdue Pharma L.P., et al. submitted.
2025-06-17
Reply of petitioners Purdue Pharma L.P., et al. filed. (Distributed)
2025-06-02
Brief of Accord Healthcare, Inc. in opposition submitted.
2025-06-02
Brief of respondent Accord Healthcare, Inc. in opposition filed.
2025-04-30
Petition for a writ of certiorari filed. (Response due June 2, 2025)
2025-03-13
Application (24A879) granted by The Chief Justice extending the time to file until April 30, 2025.
2025-03-10
Application (24A879) to extend the time to file a petition for a writ of certiorari from March 30, 2025 to April 30, 2025, submitted to The Chief Justice.
Attorneys
Accord Healthcare, Inc.
Alejandro Menchaca — McAndrews, Held & Malloy Ltd., Respondent
Purdue Pharma L.P., et al.
Gregory George Garre — Latham & Watkins LLP, Petitioner